3-(2,2,2-trimethylhydrazine)propionate has been researched along with c-peptide in 1 studies
| Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (c-peptide) | Trials (c-peptide) | Recent Studies (post-2010) (c-peptide) |
|---|---|---|---|---|---|
| 251 | 35 | 105 | 9,053 | 1,632 | 2,445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cirule, H; Dambrova, M; Kalvinsh, I; Kuka, J; Liepinsh, E; Pugovics, O; Skapare, E; Svalbe, B; Vilskersts, R | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and c-peptide
| Article | Year |
|---|---|
Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart.
Topics: Animals; Betaine; C-Peptide; Carnitine; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Heart; Hexokinase; Male; Methylhydrazines; Mice; Mice, Inbred ICR; Myocardium; RNA, Messenger; Up-Regulation | 2008 |